ANSTO's research capabilities, led by the OPAL nuclear research reactor and associated instruments provide access to users investigating areas as diverse as materials, life sciences, climate change and mining/engineering.
Ms Cathy Jiang
Position: Analytical Chemist/QA QC Officer
Phone: +61 (0)2 9717 3586
Email: cathy.jiang@ansto.gov.au
Role at ANSTO
Cathy works in the Radiochemistry group under Dr Tien Pham and Dr Ivan Greguric.
Leading the Quality Control and Quality Assurance tasks for the Lucas Heights radiochemistry group, Cathy provides analytical support for the synthetic chemistry group.
She carries out HPLC separation, HPLC method development, and spectroscopic analysis (HPLC, MS, analytical LCMS, Prep-LCMS) of intermediate and final compounds, and HPLC metabolite analysis as needed. She also performs radiochemical purity analysis of radiolabelled final compounds, logP analysis, and specific activity calculations.
Background
Prior to her current role, Cathy worked at ARI, now known as ANSTO Health, in radiopharmaceutical production and QC Microbiology, where her role was making quality radiopharmaceuticals for hospitals and carried out microbiological testing.
Research interests and areas of expertise
Cathy’s expertise and interest lies in HPLC separation, analysis and method development, and analytical, Prep LCMS.
Qualifications & Achievements
Bachelor of Biotechnology, the University of Western Sydney
Key Publications
Peyronneau, M., Mattner, F., Howell, N., Jiang, C., Pellegrini, P., Greguric, I., Loch, C., Katsifis, A. Metabolism of CLINDE, a peripheral benzodiazepine receptor SPECT ligand. European Journal of Nuclear Medicine and Molecular Imaging, 37(2), S242. (2010)
Greguric, I., Taylor, S., Pham, T., Wyatt, N., Jiang, C., Bourdier, T., Loc'h, C., Roselt, P., Neels, O., Katsifis, A. Radiosynthesis of a novel PET fluoronicotinamide for melanoma tumour PET imaging: [18F]MEL050. Australian Journal of Chemistry, 64, 873-879. (2011)